Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: Potential application of natural compounds

S Chen, H Chen, Q Du, J Shen - Frontiers in physiology, 2020 - frontiersin.org
Oxidative stress and inflammation are two critical pathological processes of cerebral
ischemia-reperfusion injury. Myeloperoxidase (MPO) is a critical inflammatory enzyme and …

A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)

F Huang, Y Li, ELH Leung, X Liu, K Liu, Q Wang… - Pharmacological …, 2020 - Elsevier
The epidemic of pneumonia (COVID-19) caused by novel coronavirus (SARS-CoV-2)
infection has been listed as a public health emergency of international concern by the World …

Neuroprotective phytochemicals in experimental ischemic stroke: mechanisms and potential clinical applications

H Xu, E Wang, F Chen, J Xiao… - Oxidative Medicine and …, 2021 - Wiley Online Library
Ischemic stroke is a challenging disease with high mortality and disability rates, causing a
great economic and social burden worldwide. During ischemic stroke, ionic imbalance and …

Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology

H Chen, Y He, S Chen, S Qi, J Shen - Pharmacological Research, 2020 - Elsevier
Oxidative/nitrosative stress and neuroinflammation are critical pathological processes in
cerebral ischemia-reperfusion injury, and their intimate interactions mediate neuronal …

Mass spectrometry‐driven drug discovery for development of herbal medicine

A Zhang, H Sun, X Wang - Mass spectrometry reviews, 2018 - Wiley Online Library
Herbal medicine (HM) has made a major contribution to the drug discovery process with
regard to identifying products compounds. Currently, more attention has been focused on …

[HTML][HTML] Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury

T Li, W Zhang, E Hu, Z Sun, P Li, Z Yu, X Zhu… - Computational and …, 2021 - Elsevier
Traumatic brain injury (TBI) has become a leading cause of mortality, morbidity and disability
worldwide. Hydroxysafflor yellow A (HSYA) is effective in treating TBI, but the potential …

NPCDR: natural product-based drug combination and its disease-specific molecular regulation

X Sun, Y Zhang, Y Zhou, X Lian, L Yan… - Nucleic acids …, 2022 - academic.oup.com
Natural product (NP) has a long history in promoting modern drug discovery, which has
derived or inspired a large number of currently prescribed drugs. Recently, the NPs have …

Glycyrrhizin prevents hemorrhagic transformation and improves neurological outcome in ischemic stroke with delayed thrombolysis through targeting peroxynitrite …

H Chen, B Guan, B Wang, H Pu, X Bai, X Chen… - Translational Stroke …, 2020 - Springer
Peroxynitrite (ONOO−) and high mobility group box 1 protein (HMGB1) are important
cytotoxic factors contributing to cerebral ischemia-reperfusion injury. However, the roles of …

Baicalin attenuates blood-brain barrier disruption and hemorrhagic transformation and improves neurological outcome in ischemic stroke rats with delayed t-PA …

H Chen, B Guan, X Chen, X Chen, C Li, J Qiu… - Translational Stroke …, 2018 - Springer
Tissue plasminogen activator (t-PA) has a restrictive therapeutic window within 4.5 h after
ischemic stroke with the risk of hemorrhagic transformation (HT) and neurotoxicity when it is …

Neuroinflammation and anti-inflammatory therapy for ischemic stroke

Y Cao, X Yue, M Jia, J Wang - Heliyon, 2023 - cell.com
Stroke remains one of the most devastating and challenging neurological diseases
worldwide. Inflammation, as well as oxidative stress is one of the main contributors to post …